INTRODUCTION
Necrotizing enterocolitis is a common and often life-threatening gastrointestinal disorder that predominately affects premature infants. It induces a multisystem inflammatory process that results in a 20-50% mortality rate. [1] [2] [3] [4] [5] [6] [7] [8] [9] Survivors often suffer extensive morbidity that includes intestinal stricture (15-30%), short bowel syndrome requiring prolonged parenteral nutrition, and cholestatic liver disease (50-60%). 1, [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] Many infants with Bell stage II or III NEC require surgery. Surgical indications include bowel perforation, worsening clinical status despite maximal medical therapy, and stricture. [16] [17] [18] Owing to the high (approximately 50%) mortality rate associated with surgery, supportive medical therapy is the initial preferred treatment offered to most affected infants. [19] [20] [21] [22] Identification of the proper indications and timing of surgery for infants with NEC has been debated for some time. The presence of portal venous air on KUB or ultrasound has been found to be a highly specific indicator of intestinal gangrene, and is considered to be a relative indication for surgical intervention. 18,21 -23 However, many infants with NEC develop bowel necrosis without demonstrating portal venous air. The presence of thrombocytopenia has been associated with more severe exacerbations of NEC resulting in intestinal gangrene and death, but investigators have found conflicting results when using thrombocytopenia as a predictor of necessary surgical intervention. [24] [25] [26] [27] [28] [29] [30] Early studies demonstrated that thrombocytopenia had a low predictive value for the presence of intestinal gangrene necessitating laparotomy. 22, 25 However, more recent studies by Ververidis et al. and Ragazzi et al. have challenged these earlier findings. They showed that severe thrombocytopenia (a platelet count <100,000/mm 3 ) has a predictive value of 89% in predicting the presence of intestinal gangrene found at laparotomy; however, the sensitivity and specificity of thrombocytopenia was low. 28, 29 In addition, in the study by Ververidis et al. 28 demonstrated bacteremia was present in a significant percentage of infants with thrombocytopenia, possibly confounding their findings.
In the present study, we hypothesized that early severe thrombocytopenia (platelet count <100,000/mm 3 within 3 days of diagnosis) in infants with NEC would be a predictor of acute gastrointestinal complications and the need for surgical intervention. In addition, we hypothesized that persistent severe thrombocytopenia (more than 3 weeks) would be associated with an increased risk of developing chronic gastrointestinal complications and death.
MATERIALS AND METHODS
The clinical presentations and outcomes of all infants with NEC diagnosed at Texas Children's Hospital between 1997 and 2001 were retrospectively reviewed. The Institutional Review Board for human subject research at Baylor College of Medicine approved the study. Infants were included in the study if they had Bell's stages II and III NEC. 16 In order to meet inclusion criteria, those infants with NEC managed by supportive medical therapy alone were required to show X-ray findings consistent with Bell's stage II NEC (pneumatosis or portal venous air). Exclusion criteria included those patients with incomplete medical records or those whose clinical and/or surgical findings were consistent with an isolated, spontaneous perforation. 31 Study patients were divided into two groups based on the lowest platelet count obtained within 3 days of NEC diagnosis (Group 1: platelet count <100,000/mm 3 ; Group 2: platelet count Z100,000/ mm 3 ). The platelet count of 100,000/mm 3 was chosen based on previous studies that demonstrated that a platelet count of less than 100,000/mm 3 had a positive predictive value of 89% in predicting intestinal gangrene in infants with NEC. 28, 29 Birth weight, gestational age, and other epidemiologic criteria were compared between the two groups. Bowel necrosis was considered absent in those patients who were treated medically and regained normal bowel function without surgical intervention. The operative notes and pathology reports of infants undergoing laparotomy were reviewed for the presence of gangrenous bowel. Other outcomes evaluated included mortality (death before hospital discharge), short bowel syndrome (defined as need for parenteral nutrition beyond 60 days), and presence or absence of cholestatic liver disease (direct bilirubin >2.0 mg/dl in conjunction with an alkaline phosphatase >375 U/l). We also evaluated the effect of early salvage laparotomy (laparotomy performed within 72 hours of NEC diagnosis) in the presence of severe thrombocytopenia.
In order to determine if persistent thrombocytopenia was also predictive of a poor outcome, patients who had severe thrombocytopenia by 3 weeks after the initial diagnosis of NEC were compared to those who had a platelet count Z100,000/mm 3 by this time period. Those patients who died before the 3-week time point were removed from this specific outcome analysis. Patients who did not have a platelet count recorded at the 3-week time point but were alive were assigned a platelet count above or below 100,000/mm 3 based on flanking counts recorded 1 week earlier and later. If both of the flanking counts were above or below 100,000/mm 3 than a presumed value was assigned accordingly. If the flanking values were conflicting F that is, one value was Z100,000/mm 3 and the other below 100,000/mm 3 F than no value was assigned, and these patients were also excluded from this secondary analysis.
In order to determine the association between platelet count and adverse neonatal outcome for the total population of study infants, we compared the mean and median platelet counts of those infants who died to those who lived, and of those infants who required surgical intervention to those who did not. Log transformation of the platelet count was used to estimate skewed data. These groups were then compared using a t-test for independent groups or a Mann-Whitney test as indicated. Log transformation of the platelet count and parametric comparison of the mean and standard deviation was also conducted to eliminate skewed data. Results were plotted on box-plot graph.
Comparison between groups with respect to baseline characteristics was conducted using an independent group t-test for continuous variables and a w 2 -test for dichotomous variables. Multiple logistic regression (MINITAB) was used to estimate odds ratios relating thrombocytopenia (independent variable) to outcome (laparotomy, short bowel syndrome and/or cholestasis, and death). Odds ratios were calculated while adjusting for birth weight, gender, gestational age, the presence or absence of positive blood cultures, and the receipt of indomethacin and postnatal steroids prior to the onset of NEC.
RESULTS
We identified 147 patients diagnosed with NEC during the study period. Of this number, 91 patients met inclusion criteria (average birth weight 1288±135 g; average gestational age 29±3 weeks). A total of 43 patients were excluded due to incomplete records resulting from flood damage from Tropical Storm Allison. In total, 13 patients had Bell's Stage I disease. Of those infants that met inclusion criteria, 47 (52%) developed thrombocytopenia within 3 days of diagnosis (Group 1). In all, 34% of these infants developed severe thrombocytopenia on the first day of clinical symptoms. These infants were slightly more premature, were more likely to have received postnatal steroids, and were more likely to have positive blood cultures when compared to the 44 patients who had a platelet count Z100,000/mm 3 (Group 2) ( Table 1) . Birth weight, gender, indomethacin use, feeding preference, and umbilical arterial line placement were otherwise similar between the two groups. Steroids were administered on average of 9.1±8.6 days prior to the onset of NEC. The average course of steroids was 7.8±7.9 days. With few exceptions, the majority of these patients received dexamethasone.
Adjusted odds ratio calculations revealed that infants with severe thrombocytopenia (Group 1) had higher rates of NEC-related gastrointestinal complications (short bowel syndrome and cholestasis) and death when compared to those infants in Group 2 ( Table 2 ). In addition, infants with severe thrombocytopenia were much more likely to require laparotomy than those in Group 2.
Overall, the mean and median platelet counts of those who died were significantly lower than those who lived (152±304,000/mm 3 vs 345±367,000/mm 3 ; p ¼ 0.012; 33,000/mm 3 vs 203,000/mm 3 ; p<0.001) (Figure 1 ). Similar results were found when comparing the platelet counts of those who needed laparotomy vs those who did not need surgical intervention. Mean and median platelet count of those requiring laparotomy compared to those managed without surgical intervention were 157±260,000/mm 3 versus 472±402,000/mm 3 (p<0.001), and 57,000/mm 3 vs 334,000/mm 3 (p<0.001), respectively. Groups were compared with and without adjustment for baseline covariates. The differences were similar and the significance remained unchanged. Similar odds ratios indicating a higher likelihood of poor outcome were noted for those infants demonstrating persistent severe thrombocytopenia by 3 weeks after the initial diagnosis of NEC. A total of 14 patients were eliminated from this analysis either because of incomplete data (n ¼ 1) or because the patient died before these time points were reached (n ¼ 13; 12 from group 1, 1 from group 2). Patients (n ¼ 17) with progressive or persistent severe thrombocytopenia by week 3 were more likely to be born at a lower gestational age (26.
Surgical procedures were performed in a total of 61/91 total study patients (67%) (data not shown). There was no standardization of surgical therapy, with decisions made by the individual attending surgeon based on clinical data. For those infants in Group 1 that required surgery, bowel necrosis was present in 92.1%. Interestingly, many of the surgical procedures were performed weeks to months after their initial diagnosis of NEC. In total, 54% (33/61) of patients underwent surgery within 1 week of diagnosis. Of these patients, 6/33 (18.2%) had placement of peritoneal drains alone and 25/33 (75.8%) underwent 
SIGNIFICANCE
In this study, of the 91 patients with Bell stage II or III NEC, those infants with early or persistent severe thrombocytopenia were more likely to have an adverse neonatal outcome (increased mortality and morbidity) and were more likely to require surgical intervention for NEC-associated bowel gangrene. Our study also demonstrates that those patients with NEC that required laparotomy or died had significantly lower mean and median platelet counts than those patients who lived or did not require surgical intervention. Our findings are similar to recent studies performed by Ververidis et al. 28 and Ragazzi et al. 29 While Ververidis et al. used the nadir and the rate of fall of the platelet count during the course of the disease, Ragazzi et al. looked at the first platelet count obtained after the diagnosis of NEC. Both found a positive correlation between thrombocytopenia and prediction of mortality and bowel necrosis. In the present study, we chose a platelet count drawn within 3 days of NEC, because we have seen anecdotally that many infants that present with Bell's stage II NEC do not have thrombocytopenia at the time of diagnosis, but develop thrombocytopenia with progression of disease. Our data also demonstrate that those infants who have persistent or progressive severe thrombocytopenia by 3 weeks after the initial diagnosis of NEC have increased mortality, increased morbidity, and are more likely to require laparotomy for bowel necrosis. In particular, this is the first study to demonstrate that those infants with persistent severe thrombocytopenia following NEC are more likely to develop cholestatic liver disease and short bowel syndrome.
Although mortality and morbidity among patients affected with NEC has decreased in recent years, the decrease has mostly been attributed to the improvement in physicians' abilities to support the sick neonate. Medical and surgical management of NEC has remained virtually unchanged since the 1970s. Research to improve the treatment of NEC has been hampered by a lack of accurate staging and a lack of reliable predictors of outcome. The findings from our study support the conviction that serial measurements of platelet counts in infants with NEC can help guide medical and surgical management and offer some prognostic indices for discussions with families.
The timing of surgery and the type of procedure to perform in a patient with NEC remain unsolved questions. Although there are reports that early laparotomy, particularly before the onset of perforation, improves mortality, morbidity, or progression of bowel necrosis, other studies have failed to demonstrate a correlation between timing of laparotomy and patient outcome. 8, 9, [32] [33] [34] Recent studies have suggested that initial percutaneous drain placement, followed by laparotomy when indicated, could improve the morbidity and mortality outcome for infants with spontaneous perforations, but consistent improvement in the outcome for those patients with NEC has yet to be demonstrated. 31,35 -40 A recent meta-analysis by Moss et al. 40 reviewed the management of babies affected with perforated NEC. His group found that although the mortality rate was higher for those whose initial management was with a peritoneal drain, these patients were generally of lower gestational age and lower birth weight. No conclusions could be made as to what the optimal management strategy should be for these patients. This important question will hopefully be answered by an ongoing prospective randomized trial comparing peritoneal drainage to laparotomy in infants with NEC.
We have demonstrated that severe early thrombocytopenia could be an indicator of bowel wall necrosis in infants with NEC. Many studies suggest that there is a direct correlation between bowel necrosis and thrombocytopenia, perhaps mediated by the cytokine, platelet activating factor (PAF). 30, 41, 42 PAF is a phospholipid produced by inflammatory cells, endothelial cells, platelets, and intestinal bacteria. [41] [42] [43] In a model of NEC developed in adult rats, injection of lipopolysacharides (LPS), a toxic biproduct of Escherichia coli that induces production of PAF, or the injection of PAF itself, induces shock and intestinal necrosis. LPS injection has also been demonstrated to induce a fall in the platelet count in human volunteers. 44 PAF is theorized to rise in the presence of infection, inflammation, and hypoxia. 45 PAF then can induce the activation of inflammatory neutrophils, the production of reactive oxygen radicals, and the production of tumor necrosis factor (TNF) F all of which contribute to bowel injury and necrosis. 30, [46] [47] [48] [49] [50] [51] [52] Our study does have several limitations that should be noted. Owing to the retrospective nature of the study, there is bound to be some inherent bias. The smaller birth weight and increased prematurity of patients in group 1 may have contributed to their adverse outcomes. 3, 7, 53 However, when we controlled for birth weight and gestastional age and stratified outcomes based on platelet count alone, we found a marked increased morbidity, mortality, and need for surgical intervention in those patients with lower mean and median platelet counts, strongly supporting the association between low platelet count and adverse neonatal outcome in patients with NEC. Given the retrospective nature of the study, however, we cannot rule out the potential for physician bias in determining which patients were chosen for surgical intervention, and this could confound our results. We also note that a higher portion of patients in our study who received postnatal steroids experienced severe thrombocytopenia. To the best of our knowledge, the use of postnatal steroids have not been associated with thrombocytopenia. Postnatal steroids, however, tend to be a predisposing factor for the development of spontaneous perforations without evidence of NEC, 54 and it is possible that a more severe form of NEC characterized by bowel necrosis could be induced by postnatal steroid use. It should be noted, however, that the odds ratios were adjusted for birth weight, gestational age, and steroid use, and they still indicate a high risk for worse outcome in the presence of severe thrombocytopenia. Although our results indicate severe thrombocytopenia can indicate bowel wall gangrene, the inherent biased nature of a retrospective study does not allow us to draw any firm conclusions as to what the optimal timing of salvage laparotomy should be. Indeed, our results find no significant differences in the outcomes between those who received early surgery (r72 hours after onset of NEC) and those who received laparotomy or percutaneous drain placement later in their hospital course. Our numbers are small, however, and we believe that this question could be answered with a large prospective trial. In addition to severe thrombocytopenia, other laboratory indicators of systemic inflammatory conditions might aid in determining those infants that are predisposed to cholestasis and short bowel syndrome, such as C-reactive protein and interleukin 6. 55, 56 Although these would have been interesting to evaluate our NICU does not normally test for these, and we therefore could not look at these values retrospectively.
In this large retrospective review of premature infants with Bell's stage II-III NEC, a platelet count of <100,000/mm 3 within the first 3 days of the course of NEC predicted bowel pathology necessitating laparotomy and subsequent mortality and morbidity. In addition, infants with persistent or progressive severe thrombocytopenia following NEC remained more likely to need laparotomy for bowel necrosis and have an increased mortality rate when compared to those whose platelet counts were Z100,000/ mm 3 at this time period. Therefore, we conclude that serial measurements of platelet counts in premature infants with NEC can predict important adverse outcomes and the need for surgical intervention, and offers a potentially useful biochemical marker for future studies designed to explore therapeutic strategies for these critically ill children. We emphasize, however, that this study alone cannot support the use of a platelet count as the sole predictor for the need for surgery. Thrombocytopenia in the presence of other clinical, radiographic, and laboratory signs may help in determining the need for laparotomy.
